Rotte Anand相关文献与解析，生知库 | 链接生命科学的每一步

Editorial: Emerging learnings in cell therapy: novel binding domains, universal CAR-T cells, and more

社论：细胞治疗领域的新进展：新型结合域、通用CAR-T细胞等等

期刊:Frontiers in Oncology

影响因子:3.3

doi:10.3389/fonc.2024.1404376

Dose fractionation of CAR-T cells. A systematic review of clinical outcomes

CAR-T细胞剂量分割：临床结果的系统评价

期刊:Journal of Experimental & Clinical Cancer Research

影响因子:12.8

doi:10.1186/s13046-022-02540-w

Frigault, Matthew; Rotte, Anand; Ansari, Ayub; Gliner, Bradford; Heery, Christopher; Shah, Bijal

Predictive models for response and survival in patients treated with anti-PD-1 monotherapy or with anti-PD-1 and ipilimumab combination: editorial commentary

预测接受抗PD-1单药治疗或抗PD-1联合伊匹木单抗治疗患者的疗效和生存期的模型：社论评论

期刊:Annals of Translational Medicine

影响因子:

doi:10.21037/atm-22-6564

Dose-response correlation for CAR-T cells: a systematic review of clinical studies

CAR-T细胞的剂量反应相关性：临床研究的系统评价

期刊:Journal for ImmunoTherapy of Cancer

影响因子:10.6

doi:10.1136/jitc-2022-005678

Rotte, Anand; Frigault, Matthew J; Ansari, Ayub; Gliner, Brad; Heery, Christopher; Shah, Bijal

Concept of the Number Needed to Treat for the Analysis of Pain Relief Outcomes in Patients Treated with Spinal Cord Stimulation

脊髓刺激治疗患者疼痛缓解结果分析中所需治疗人数的概念

期刊:Biomedicines

影响因子:3.9

doi:10.3390/biomedicines10020497

Bailey-Classen, Ashley; Parikh, Amar; Adimi, Nima; Edgar, Deborah; Yan, Alice; Rotte, Anand; Caraway, David

神经科学

发表日期：2022

文献求助收藏

Pharmacology-based ranking of anti-cancer drugs to guide clinical development of cancer immunotherapy combinations

基于药理学的抗癌药物排名，以指导癌症免疫疗法组合的临床开发

期刊:Journal of Experimental & Clinical Cancer Research

影响因子:12.8

doi:10.1186/s13046-021-02111-5

Lemaire, Vincent; Shemesh, Colby S; Rotte, Anand

Personalized Cancer Vaccines: Clinical Landscape, Challenges, and Opportunities

个性化癌症疫苗：临床现状、挑战与机遇

期刊:Molecular Therapy

影响因子:12

doi:10.1016/j.ymthe.2020.09.038

Shemesh, Colby S; Hsu, Joy C; Hosseini, Iraj; Shen, Ben-Quan; Rotte, Anand; Twomey, Patrick; Girish, Sandhya; Wu, Benjamin

Targeting TIGIT for Immunotherapy of Cancer: Update on Clinical Development

靶向TIGIT的癌症免疫疗法：临床研发最新进展

期刊:Biomedicines

影响因子:3.9

doi:10.3390/biomedicines9091277

Rotte, Anand; Sahasranaman, Srikumar; Budha, Nageshwar

Pain Relief and Safety Outcomes with Cervical 10 kHz Spinal Cord Stimulation: Systematic Literature Review and Meta-analysis

颈椎10 kHz脊髓刺激的镇痛效果和安全性结果：系统文献综述和荟萃分析

期刊:Pain and Therapy

影响因子:3.3

doi:10.1007/s40122-021-00269-6

Baranidharan, Ganesan; Bretherton, Beatrice; Montgomery, Craig; Titterington, John; Crowther, Tracey; Vannabouathong, Christopher; Inzana, Jason A; Rotte, Anand

神经科学

发表日期：2021

文献求助收藏

Targeting T-Cells for Cancer Treatment: Current Clinical Strategies and Challenges

靶向T细胞治疗癌症：当前临床策略与挑战

Editorial: Emerging learnings in cell therapy: novel binding domains, universal CAR-T cells, and more

社论：细胞治疗领域的新进展：新型结合域、通用CAR-T细胞等等

Dose fractionation of CAR-T cells. A systematic review of clinical outcomes

CAR-T细胞剂量分割：临床结果的系统评价

Predictive models for response and survival in patients treated with anti-PD-1 monotherapy or with anti-PD-1 and ipilimumab combination: editorial commentary

预测接受抗PD-1单药治疗或抗PD-1联合伊匹木单抗治疗患者的疗效和生存期的模型：社论评论

Dose-response correlation for CAR-T cells: a systematic review of clinical studies

CAR-T细胞的剂量反应相关性：临床研究的系统评价

Concept of the Number Needed to Treat for the Analysis of Pain Relief Outcomes in Patients Treated with Spinal Cord Stimulation

脊髓刺激治疗患者疼痛缓解结果分析中所需治疗人数的概念

Pharmacology-based ranking of anti-cancer drugs to guide clinical development of cancer immunotherapy combinations

基于药理学的抗癌药物排名，以指导癌症免疫疗法组合的临床开发

Personalized Cancer Vaccines: Clinical Landscape, Challenges, and Opportunities

个性化癌症疫苗：临床现状、挑战与机遇

Targeting TIGIT for Immunotherapy of Cancer: Update on Clinical Development

靶向TIGIT的癌症免疫疗法：临床研发最新进展

Pain Relief and Safety Outcomes with Cervical 10 kHz Spinal Cord Stimulation: Systematic Literature Review and Meta-analysis

颈椎10 kHz脊髓刺激的镇痛效果和安全性结果：系统文献综述和荟萃分析